102169-44-8

Basic information

• Product Name: 4-broMo-5-Methylbenzene-1,2-diaMine
• Synonyms: 4-broMo-5-Methylbenzene-1,2-diaMine;1,2-BenzenediaMine, 4-broMo-5-Methyl-;4-Bromo-5-methyl-1,2-benzenediamine
• CAS NO: 102169-44-8
• Molecular Formula: C₇H₉BrN₂
• Molecular Weight: 201.06376
• Mol File: 102169-44-8.mol

Chemical Properties

• Boiling Point: 298.6±35.0 °C(Predicted)
• Appearance: /
• Density: 1.589±0.06 g/cm3(Predicted)
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 3.58±0.10(Predicted)
• CAS DataBase Reference: 4-broMo-5-Methylbenzene-1,2-diaMine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-broMo-5-Methylbenzene-1,2-diaMine(102169-44-8)
• EPA Substance Registry System: 4-broMo-5-Methylbenzene-1,2-diaMine(102169-44-8)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• WGK Germany: 3
• Hazardous Substances Data: 102169-44-8(Hazardous Substances Data)

Usage

Uses

Used in Personal Care Products:
4-Bromo-5-methylbenzene-1,2-diamine is used as a preservative in personal care products such as cosmetics, toiletries, and skincare products. It helps maintain the freshness and quality of these products by preventing the growth of bacteria, fungi, and yeasts.
Used in Industrial Applications:
In the industrial sector, 4-Bromo-5-methylbenzene-1,2-diamine is used as an antimicrobial agent in various applications, including water treatment, paper production, and paint and coating formulations. It helps protect these products from microbial contamination, ensuring their durability and performance.
However, it is crucial to handle 4-Bromo-5-methylbenzene-1,2-diamine with care, as it has been associated with skin irritation and allergic reactions in some individuals. Proper safety measures should be taken during its use to minimize potential health risks.

Upstream product

• 40371-63-9 5-bromo-4-methyl-2-nitroaniline 
• 89-62-3 4-methyl-2-nitroaniline 
• 827-32-7 4-bromo-5-methyl-2-nitrophenylamine 
• 335342-96-6 4-bromo-5-methyl-1,2-di(tosylamino)benzene 
• 70376-38-4 N,N'-(4-methyl-1,2-phenylene)bis(4-methylbenzenesulfonamide) 
• 496-72-0 4-methyl-1,2-diaminobenzene 
• 7745-93-9 2-bromo-4-nitrotoluene 
• 857001-14-0 2-bromo-4,5-dinitro-toluene 

Downstream Products

• 116106-16-2 5-bromo-6-methyl-1H-benzo[d]imidazole 

Relevant articles and documents

Benzo[c][1,2,5]thiadiazole Donor-Acceptor Dyes: A Synthetic, Spectroscopic, and Computational Study

The synthesis, optical characterization and computational modeling of seven benzo[c][1,2,5]thiadiazole (BTD) donor-acceptor dyes are reported. These dyes have been studied using electrochemical analysis, electronic absorption, emission, and Raman and resonance Raman spectroscopies coupled with various density functional theoretical approaches. Crystal structure geometries on a number of these compounds are also reported. The optical spectra are dominated by low energy charge-transfer states; this may be modulated by the coupling between donor and acceptor through variation in donor energy, variation of the donor-acceptor torsion angle, and incorporation of an insulating bridge. These modifications result in a perturbation of the excitation energy for this charge-transfer transition of up to ～2000 cm-1. Emission spectra exhibit significant solvatochromisim, with Lippert-Mataga analysis yielding Δμ between 8 and 33 D. Predicted λmax, ε, and Raman cross sections calculated by M06L, B3LYP, PBE0, M06, CAM-B3LYP, and ωB97XD DFT functionals were compared to experimental results and analyzed using multivariate analysis, which shows that hybrid functionals with 20-27% HF best predict ground state absorption, while long-range corrected functionals best predict molecular polarizabilities.

SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF

The present application relates to novel substituted 5-aminopyrazoles, methods of production thereof, use thereof alone or in combinations for the treatment and/or prophylaxis of diseases and use thereof for the production of medicinal products for the treatment and/or prophylaxis of diseases.

Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes

The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating RXR mediated disorders. More particularly, the compounds of the present invention are RXR agonists useful for treating RXR mediated disorders.